The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Compass Therapeutics Inc (NASDAQ: CMPX) closed at $1.70 in the last session, down -1.16% from day before closing price of $1.72. In other words, the price has decreased by -$1.16 from its previous closing price. On the day, 0.56 million shares were traded. CMPX stock price reached its highest trading level at $1.775 during the session, while it also had its lowest trading level at $1.635.
Ratios:
We take a closer look at CMPX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 14.96 and its Current Ratio is at 14.96. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On February 24, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.
On February 19, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $12.Piper Sandler initiated its Overweight rating on February 19, 2025, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 09 ’25 when GORDON CARL L sold 3,571,428 shares for $1.59 per share. The transaction valued at 5,678,571 led to the insider holds 0 shares of the business.
ORBIMED ADVISORS LLC sold 3,571,428 shares of CMPX for $5,678,571 on Apr 09 ’25. The Director now owns 0 shares after completing the transaction at $1.59 per share. On Apr 09 ’25, another insider, OrbiMed Genesis Master Fund, L, who serves as the Director of the company, bought 3,571,428 shares for $1.59 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 235079408 and an Enterprise Value of 114992248. For the stock, the TTM Price-to-Sale (P/S) ratio is 276.57 while its Price-to-Book (P/B) ratio in mrq is 1.87. Its current Enterprise Value per Revenue stands at 135.285 whereas that against EBITDA is -2.052.
Stock Price History:
The Beta on a monthly basis for CMPX is 1.21, which has changed by 0.111111164 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, CMPX has reached a high of $4.08, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is -33.43%, while the 200-Day Moving Average is calculated to be -6.92%.
Shares Statistics:
According to the various share statistics, CMPX traded on average about 1.72M shares per day over the past 3-months and 2404180 shares per day over the past 10 days. A total of 137.82M shares are outstanding, with a floating share count of 80.66M. Insiders hold about 41.67% of the company’s shares, while institutions hold 38.85% stake in the company. Shares short for CMPX as of 1743379200 were 6618254 with a Short Ratio of 3.84, compared to 1740700800 on 3695821. Therefore, it implies a Short% of Shares Outstanding of 6618254 and a Short% of Float of 6.75.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
